Paper7040367
Purification and further characterization of the Ca2+-activated proteinase specific for the intermediate filament proteins vimentin and desmin.
Nelson WJ and 1 other. J Biol Chem, 1982. Cited by 150 papers, by iCite.
Cite this record
ConductScience Library. Purification and further characterization of the Ca2+-activated proteinase specific for the intermediate filament proteins vimentin and desmin. Papers, record 7040367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7040367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Purification and further characterization of the Ca2+-activated proteinase specific for the intermediate filament proteins vimentin and desmin.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium | Major topic |
| Carcinoma, Ehrlich Tumor | Major topic |
| Cytoplasmic Granules | Major topic |
| Muscle Proteins | Major topic |
| Peptide Hydrolases | Major topic |
| Animals | |
| Desmin | |
| Enzyme Activation | |
| Kinetics | |
| Mice | |
| Molecular Weight | |
| Vimentin |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32663035 | Cellular Mechanisms of NETosis. | Annu Rev Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32663035 | PubMed |
| 28955862 | Increased level of phosphorylated desmin and its degradation products in heart failure. | Biochem Biophys Rep | 2016 | https://conductscience.org/library/papers/28955862 | PubMed |
| 28620205 | An anti vimentin antibody promotes tube formation. | Sci Rep | 2017 | https://conductscience.org/library/papers/28620205 | PubMed |
| 24351716 | Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry. | Toxins (Basel) | 2013 | https://conductscience.org/library/papers/24351716 | PubMed |
| 21455778 | Alterations in the lenticular protein profile in experimental selenite-induced cataractogenesis and prevention by ellagic acid. | Graefes Arch Clin Exp Ophthalmol | 2011 | https://conductscience.org/library/papers/21455778 | PubMed |
| 18539904 | A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization. | FASEB J | 2008 | https://conductscience.org/library/papers/18539904 | PubMed |
| 18472024 | Proteomic profiling of endothelin-1-stimulated hypertrophic cardiomyocytes reveals the increase of four different desmin species and alpha-B-crystallin. | Biochim Biophys Acta | 2008 | https://conductscience.org/library/papers/18472024 | PubMed |
| 12739614 | Muscle fibre breakdown in venom-induced muscle degeneration. | J Anat | 2003 | https://conductscience.org/library/papers/12739614 | PubMed |
| 11519732 | Mechanism of myelin breakdown in experimental demyelination: a putative role for calpain. | Neurochem Res | 2001 | https://conductscience.org/library/papers/11519732 | PubMed |
| 10500203 | A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10500203 | PubMed |
| 9247605 | Regulation of vimentin expression and protease-mediated vimentin degradation during differentiation of human monocytic leukemia cells. | Jpn J Cancer Res | 1997 | https://conductscience.org/library/papers/9247605 | PubMed |
| 9172071 | Fish muscle cytoskeleton integrity is not dependent on intact thin filaments. | J Muscle Res Cell Motil | 1997 | https://conductscience.org/library/papers/9172071 | PubMed |
| 8510675 | Calpain processing of brain microtubules from the Atlantic cod, Gadus morhua. | Mol Cell Biochem | 1993 | https://conductscience.org/library/papers/8510675 | PubMed |
| 7707359 | Endogenous, Ca(2+)-dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle. | J Membr Biol | 1994 | https://conductscience.org/library/papers/7707359 | PubMed |
| 7162514 | Interaction of the intermediate filament protein vimentin with ribosomal subunits and ribosomal RNA in vitro. | Mol Biol Rep | 1982 | https://conductscience.org/library/papers/7162514 | PubMed |
| 6682861 | Vimentin filaments are assembled from a soluble precursor in avian erythroid cells. | J Cell Biol | 1983 | https://conductscience.org/library/papers/6682861 | PubMed |
| 6434549 | Intermediate-sized filaments in Drosophila tissue culture cells. | J Cell Biol | 1984 | https://conductscience.org/library/papers/6434549 | PubMed |
| 6330596 | Purification and partial characterization of two forms of Ca2+-activated neutral protease from calf brain synaptosomes and spinal cord. | Neurochem Res | 1984 | https://conductscience.org/library/papers/6330596 | PubMed |
| 6318144 | Purification of a calcium-activated neutral proteinase from bovine brain. | Neurochem Res | 1983 | https://conductscience.org/library/papers/6318144 | PubMed |
| 6308428 | Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins. | Mol Cell Biol | 1983 | https://conductscience.org/library/papers/6308428 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7040367
GET https://conductscience.org/api/papers/v1/7040367/cited_by?page=2